These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 15234279

  • 1. Topical prophylaxis with moxifloxacin prevents endophthalmitis in a rabbit model.
    Kowalski RP, Romanowski EG, Mah FS, Yates KA, Gordon YJ.
    Am J Ophthalmol; 2004 Jul; 138(1):33-7. PubMed ID: 15234279
    [Abstract] [Full Text] [Related]

  • 2. Intracameral Vigamox (moxifloxacin 0.5%) is non-toxic and effective in preventing endophthalmitis in a rabbit model.
    Kowalski RP, Romanowski EG, Mah FS, Yates KA, Gordon YJ.
    Am J Ophthalmol; 2005 Sep; 140(3):497-504. PubMed ID: 16083841
    [Abstract] [Full Text] [Related]

  • 3. Prevention of endophthalmitis by collagen shields presoaked in fourth-generation fluoroquinolones versus by topical prophylaxis.
    Haugen B, Werner L, Romaniv N, Haymore J, Kleinmann G, Mamalis N, Olson RJ.
    J Cataract Refract Surg; 2008 May; 34(5):853-8. PubMed ID: 18471646
    [Abstract] [Full Text] [Related]

  • 4. Effects of intravitreal moxifloxacin and dexamethasone in experimental Staphylococcus aureus endophthalmitis.
    Ermis SS, Cetinkaya Z, Kiyici H, Inan UU, Ozturk F.
    Curr Eye Res; 2007 Apr; 32(4):337-44. PubMed ID: 17453955
    [Abstract] [Full Text] [Related]

  • 5. Topical 0.5% moxifloxacin prevents endophthalmitis in an intravitreal injection rabbit model.
    Kowalski RP, Romanowski EG, Mah FS, Yates KA, Gordon YJ.
    J Ocul Pharmacol Ther; 2008 Feb; 24(1):1-7. PubMed ID: 18370872
    [Abstract] [Full Text] [Related]

  • 6. A comparison of moxifloxacin and levofloxacin topical prophylaxis in a fluoroquinolone-resistant Staphylococcus aureus rabbit model.
    Kowalski RP, Romanowski EG, Mah FS, Sasaki H, Fukuda M, Gordon YJ.
    Jpn J Ophthalmol; 2008 Feb; 52(3):211-216. PubMed ID: 18661272
    [Abstract] [Full Text] [Related]

  • 7. The effect of cataract surgery on ocular levels of topical moxifloxacin.
    Mather R, Stewart JM, Prabriputaloong T, Wong J, McLeod SD.
    Am J Ophthalmol; 2004 Oct; 138(4):554-9. PubMed ID: 15488780
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Comparison of 2 moxifloxacin regimens for preoperative prophylaxis: prospective randomized triple-masked trial. Part 1: aqueous concentration of moxifloxacin.
    Vasavada AR, Gajjar D, Raj SM, Vasavada V, Vasavada V.
    J Cataract Refract Surg; 2008 Aug; 34(8):1379-82. PubMed ID: 18655991
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Penetration of second-, third-, and fourth-generation topical fluoroquinolone into aqueous and vitreous humour in a rabbit endophthalmitis model.
    Yağci R, Oflu Y, Dinçel A, Kaya E, Yağci S, Bayar B, Duman S, Bozkurt A.
    Eye (Lond); 2007 Jul; 21(7):990-4. PubMed ID: 16732216
    [Abstract] [Full Text] [Related]

  • 20. A highly virulent Staphylococcus aureus: rabbit anterior chamber infection, characterization, and genetic analysis.
    Balzli CL, Bartell J, Dajcs JJ, McCormick CC, Caballero AR, Stroman D, O'Callaghan RJ.
    Invest Ophthalmol Vis Sci; 2010 Oct; 51(10):5114-20. PubMed ID: 20463315
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.